Literature DB >> 27870810

Neonatal Group B Streptococcus Infections: Prevention Strategies, Clinical and Microbiologic Characteristics in 7 Years of Surveillance.

Roberta Creti1, Monica Imperi, Alberto Berardi, Marco Pataracchia, Simona Recchia, Giovanna Alfarone, Lucilla Baldassarri.   

Abstract

BACKGROUND: The characteristics of group B streptococcus (GBS) neonatal disease in a period of 7 years are reported.
METHODS: The estimation of the neonatal GBS disease risk and prevention strategies adopted at delivery in absence of national guidelines was evaluated by the analysis of 3501 questionnaires. Notification of 194 neonatal GBS infections was recorded. In addition, 115 strains from neonatal early-onset disease (EOD) and late-onset disease, respectively, plus 320 strains from pregnant women were analyzed by molecular typing methods and for antibiotic resistance.
RESULTS: Preterm deliveries, precipitous labor and GBS negatively screened mothers were the prominent causes for an inadequate or lack of intrapartum antibiotic prophylaxis and EOD occurrence. The superimposable serotype distribution of GBS strains from EOD and from antenatal screening confirmed the vertical transmission from mother to neonate as the cause of disease. On the contrary, late-onset disease was almost exclusively caused by the internationally diffused clonal complex 17. Erythromycin resistance was detected in 17% of strains. Resistance to clindamycin was 15.3 %.
CONCLUSIONS: The administration of intrapartum antibiotic prophylaxis to negatively GBS screened women in presence of risk factors was a deviation from the recommendations issued by the Centers for Disease Control and Prevention, and it should deserve further consideration. Routine surveillance and molecular typing of circulating clones are essential for the effective management of the neonatal GBS disease.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27870810     DOI: 10.1097/INF.0000000000001414

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  12 in total

1.  Population structure and virulence gene profiles of Streptococcus agalactiae collected from different hosts worldwide.

Authors:  Marina Morach; Roger Stephan; Sarah Schmitt; Christa Ewers; Michael Zschöck; Julian Reyes-Velez; Urs Gilli; María Del Pilar Crespo-Ortiz; Margaret Crumlish; Revathi Gunturu; Claudia A Daubenberger; Margaret Ip; Walter Regli; Sophia Johler
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-11-27       Impact factor: 3.267

2.  Appropriate Antibiotic Use for Group B Streptococcus Prophylaxis Among Penicillin-Allergic Patients in Academic and Nonacademic Hospitals.

Authors:  Beth L Pineles; Katherine E Goodman; Lisa Pineles; Anthony D Harris
Journal:  Open Forum Infect Dis       Date:  2022-10-05       Impact factor: 4.423

3.  Vaccination With a Latch Peptide Provides Serotype-Independent Protection Against Group B Streptococcus Infection in Mice.

Authors:  Shun-Mei Lin; A-Yeung Jang; Yong Zhi; Shuang Gao; Sangyong Lim; Jae Hyang Lim; Joon Young Song; Paul M Sullam; Joon Haeng Rhee; Ho Seong Seo
Journal:  J Infect Dis       Date:  2017-12-27       Impact factor: 5.226

Review 4.  Immunization Against Group B Streptococci vs. Intrapartum Antibiotic Prophylaxis in Peripartum Pregnant Women and their Neonates: A Review.

Authors:  Mariya Kristeva; Catherine Tillman; Ashley Goordeen
Journal:  Cureus       Date:  2017-10-13

5.  Newborn colonization and antibiotic susceptibility patterns of Streptococcus agalactiae at the University of Gondar Referral Hospital, Northwest Ethiopia.

Authors:  Mucheye Gizachew; Moges Tiruneh; Feleke Moges; Mulat Adefris; Zemene Tigabu; Belay Tessema
Journal:  BMC Pediatr       Date:  2018-11-30       Impact factor: 2.125

6.  Group B streptococcus late-onset disease,contaminated breast milk and mothers persistently GBS negative: report of 3cases.

Authors:  Giangiacomo Nicolini; Martina Borellini; Vitaliana Loizzo; Roberta Creti; Luigi Memo; Alberto Berardi
Journal:  BMC Pediatr       Date:  2018-07-05       Impact factor: 2.125

7.  Knowledge, attitude and current practices of pregnant women towards group B streptococcus screening: cross-sectional study, Al-Madinah, Saudi Arabia.

Authors:  Amer Alshengeti; Amjad Alharbi; Shahad Alraddadi; Abdulsalam Alawfi; Bushra Aljohani
Journal:  BMJ Open       Date:  2020-02-12       Impact factor: 2.692

8.  Streptococcus agalactiae in pregnant women: serotype and antimicrobial susceptibility patterns over five years in Eastern Sicily (Italy).

Authors:  Carlo Genovese; Floriana D'Angeli; Valentina Di Salvatore; Gianna Tempera; Daria Nicolosi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-07-22       Impact factor: 3.267

9.  Trends in molecular characteristics and antimicrobial resistance of group B streptococci: a multicenter study in Serbia, 2015-2020.

Authors:  Dusan Kekic; Ina Gajic; Natasa Opavski; Milan Kojic; Goran Vukotic; Aleksandra Smitran; Lidija Boskovic; Marina Stojkovic; Lazar Ranin
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

10.  Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM197-Conjugate Vaccine During Pregnancy.

Authors:  Shabir A Madhi; Anthonet Koen; Clare L Cutland; Lisa Jose; Niresha Govender; Frederick Wittke; Morounfolu Olugbosi; Ajoke Sobanjo-Ter Meulen; Sherryl Baker; Peter M Dull; Vas Narasimhan; Karen Slobod
Journal:  Clin Infect Dis       Date:  2017-11-13       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.